Aşı Tabloları
Gelişim, Kılavuzlar, Tüm Yazılar
Favorime Ekle
Amerikan CDC Aşı Aralık ve Yaş Önerileri:
Hangi aşı hangi yaşta, önerilen en küçük yaş, dozlar arasında önerilen aralık Amerikan CDC önerilerinin bulunduğu sayfadan alınıktır. (orjinal belge burada)
Minimum yaş ve aşı dozları arasındaki süre için öneriler |
||||
Aşı Adı ve Doz Numarası |
Bu aşı için önerilen Yaş |
Bu aşı için önerilen minimum yaş |
Bir sonraki doz ile arasında olması önerilen aralık |
Bir sonraki doz ile arasında olması önerilen minimum aralık |
|---|---|---|---|---|
| Diphtheria-tetanus-acellular pertussis (DTaP)-15 | 2 ay | 6 hafta | 8 hafta | 4 hafta |
| DTaP-2 | 4 ay | 10 hafta | 8 hafta | 4 hafta |
| DTaP-3 | 6 ay | 14 hafta | 6-12 ay | 6 ay6 |
| DTaP-4 | 15-18 ay | 15 ay7 | 3 yıl | 6 ay |
| DTaP-5 | 4-6 yıl | 4 yıl | — | — |
| Haemophilus influenzae type b (Hib)-16,8 Hib-2 Hib-39 Hib-4 |
2 ay 4 ay 6 ay 12-15 ay |
6 hafta 10 hafta 14 hafta 12 ay |
8 hafta 8 hafta 6-9 ay — |
4 hafta 4 hafta 8 hafta — |
| Hepatitis A (HepA)-1 | 12-23 ay | 12 ay | 6-18 ay | 6 ay |
| HepA-2 | >18 ay | 18 ay | — | — |
| Hepatitis B (HepB)-15 HepB-2 HepB-310 |
Birth 1-2 ay 6-18 ay |
Birth 4 hafta 24 hafta |
4 hafta-4 ay 8 hafta-17 ay — |
4 hafta 8 hafta — |
| Herpes zoster (HZV)11 | >60 yıl | 60 yıl | — | — |
| Human papillomavirus (HPV)-112 | 11-12 yıl | 9 yıl | 8 hafta | 4 hafta |
| HPV-2 | 11-12 yıl (+ 2 ay) |
9 yıl (+ 4 hafta) |
4 ay | 12 hafta13 |
| HPV-313 | 11-12 yıl (+ 6 ay) |
9 yıl (+24 hafta) |
— | — |
| Influenza, inactivated (IIV)14 | >6 ay | 6 ay15 | 4 hafta | 4 hafta |
| Influenza, live attenuated (LAIV)14 | 2-49 yıl | 2 yıl | 4 hafta | 4 hafta |
| Measles-mumps-rubella (MMR)-116 | 12-15 ay | 12 ay | 3-5 yıl | 4 hafta |
| MMR-216 | 4-6 yıl | 13 ay | — | — |
| Meningococcal conjugate (MCV)-117 | 11-12 yıl | 6 hafta18 | 4-5 yıl | 8 hafta |
| MCV-2 | 16 yıl | 11 yıl (+ 8 hafta) |
— | — |
| Meningococcal polysaccharide (MPSV4)-117 | — | 2 yıl | 5 yıl | 5 yıl |
| MPSV4-2 | — | 7 yıl | — | — |
| Pneumococcal conjugate (PCV)-18 PCV-2 PCV-3 PCV-4 |
2 ay 4 ay 6 ay 12-15 ay |
6 hafta 10 hafta 14 hafta 12 ay |
8 hafta 8 hafta 6 ay — |
4 hafta 4 hafta 8 hafta — |
| Pneumococcal polysaccharide (PPSV)-1 | — | 2 yıl | 5 yıl | 5 yıl |
| PPSV-219 | — | 7 yıl | — | — |
| Poliovirus, Inactivated (IPV)-15 IPV-2 | 2 ay 4 ay |
6 hafta 10 hafta |
8 hafta 8 hafta-14 ay |
4 hafta 4 hafta |
| IPV-3 IPV-420 | 6-18 ay 4-6 yıl |
14 hafta 4 yıl |
3-5 yıl — |
6 ay — |
| Rotavirus (RV)-121 | 2 ay | 6 hafta | 8 hafta | 4 hafta |
| RV-2 | 4 ay | 10 hafta | 8 hafta | 4 hafta |
| RV-322 | 6 ay | 14 hafta | — | — |
| Tetanus-diphtheria (Td) | 11-12 yıl | 7 yıl | 10 yıl | 5 yıl |
| Tetanus-diphtheria-acellular pertussis (Tdap)23 | >11 yıl | 7 yıl | — | — |
| Varicella (Var)-116 | 12-15 ay | 12 ay | 3-5 yıl | 12 hafta24 |
| Var-216 | 4-6 yıl | 15 ay25 | — | — |
Türkiye Aşı Takvimi
ABD Uygulanan ve Önerilen Aşı Takvimi
Vaccine-Preventable Diseases and the Vaccines that Prevent Them
| Disease | Vaccine | Disease spread by | Disease symptoms | Disease complications |
|---|---|---|---|---|
| Chickenpox | Varicella vaccine protects against chickenpox. | Air, direct contact | Rash, tiredness, headache, fever | Infected blisters, bleeding disorders, encephalitis (brain swelling), pneumonia (infection in the lungs) |
| Diphtheria | DTaP* vaccine protects against diphtheria. | Air, direct contact | Sore throat, mild fever, weakness, swollen glands in neck | Swelling of the heart muscle, heart failure, coma, paralysis, death |
| Hib | Hib vaccine protects against Haemophilus influenzae type b. | Air, direct contact | May be no symptoms unless bacteria enter the blood | Meningitis (infection of the covering around the brain and spinal cord), intellectual disability, epiglottitis (life-threatening infection that can block the windpipe and lead to serious breathing problems), pneumonia (infection in the lungs), death |
| Hepatitis A | HepA vaccine protects against hepatitis A. | Direct contact, contaminated food or water | May be no symptoms, fever, stomach pain, loss of appetite, fatigue, vomiting, jaundice (yellowing of skin and eyes), dark urine | Liver failure, arthralgia (joint pain), kidney, pancreatic, and blood disorders |
| Hepatitis B | HepB vaccine protects against hepatitis B. | Contact with blood or body fluids | May be no symptoms, fever, headache, weakness, vomiting, jaundice (yellowing of skin and eyes), joint pain | Chronic liver infection, liver failure, liver cancer |
| Influenza (Flu) | Flu vaccine protects against influenza. | Air, direct contact | Fever, muscle pain, sore throat, cough, extreme fatigue | Pneumonia (infection in the lungs) |
| Measles | MMR** vaccine protects against measles. | Air, direct contact | Rash, fever, cough, runny nose, pinkeye | Encephalitis (brain swelling), pneumonia (infection in the lungs), death |
| Mumps | MMR**vaccine protects against mumps. | Air, direct contact | Swollen salivary glands (under the jaw), fever, headache, tiredness, muscle pain | Meningitis (infection of the covering around the brain and spinal cord) , encephalitis (brain swelling), inflam mation of testicles or ovaries, deafness |
| Pertussis | DTaP* vaccine protects against pertussis (whooping cough). | Air, direct contact | Severe cough, runny nose, apnea (a pause in breathing in infants) | Pneumonia (infection in the lungs), death |
| Polio | IPV vaccine protects against polio. | Air, direct contact, through the mouth | May be no symptoms, sore throat, fever, nausea, headache | Paralysis, death |
| Pneumococcal | PCV13 vaccine protects against pneumococcus. | Air, direct contact | May be no symptoms, pneumonia (infection in the lungs) | Bacteremia (blood infection), meningitis (infection of the covering around the brain and spinal cord), death |
| Rotavirus | RV vaccine protects against rotavirus. | Through the mouth | Diarrhea, fever, vomiting | Severe diarrhea, dehydration |
| Rubella | MMR** vaccine protects against rubella. | Air, direct contact | Children infected with rubella virus sometimes have a rash, fever, swollen lymph nodes | Very serious in pregnant women—can lead to miscarriage, stillbirth, premature delivery, birth defects |
| Tetanus | DTaP* vaccine protects against tetanus. | Exposure through cuts in skin | Stiffness in neck and abdominal muscles, difficulty swallowing, muscle spasms, fever | Broken bones, breathing difficulty, death |
